无血医学患者从头到足显微外科重建的单中心经验
本研究回顾性分析2017至2020年单中心无血医学患者(拒绝输血)接受游离组织移植(FTT)的结局,共10例患者11次FTT,平均年龄62.4岁,重建部位为乳房6例、下肢3例、头皮2例;平均手术时间390分钟,平均估计失血量170 mL,术前至首次术后血红蛋白平均下降2.2 g/dL,平均随访12个月,10例皮瓣成功,1例失败后经二次手术成功重建。
要点
- 10例无血医学患者共接受11次游离组织移植,重建部位包括乳房6例、下肢3例、头皮2例。
- 平均估计失血量170 mL,术前至首次术后血红蛋白平均下降2.2 g/dL。
- 11次皮瓣中10次成功,1例失败后经二次手术成功重建。
核心结论
- 尽管队列小且异质性高,但在这组合并症较多的患者中获得的成功率提示,无法使用血液制品的患者可有效实施游离组织移植。
- 无血医学方案有益于服务输血限制患者的提供者以及力求限制输血量和风险的系统。
研究设计与样本
- 回顾性分析单中心2017年至2020年所有接受游离组织移植的患者,筛选其中拒绝血液制品的患者。
主要发现
- 共识别10例患者接受11次游离组织移植,平均年龄62.4岁(SD 7.6)。
- 大多数患者为女性(n=9)和黑人(n=8)。
- 平均体重指数31.3(SD 5.6),美国麻醉医师协会身体状况分级2.9(SD 0.5),Charlson合并症指数3.8(SD 1.1)。
- 重建部位为乳房(6)、下肢(3)和头皮(2)。
- 平均手术时间390分钟(SD 85.1),平均估计失血量170 mL(SD 100.4)。
局限性
- 原文自述队列小且异质性高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients who decline blood transfusions, including members of the Jehovah's Witness faith, often face challenges when they require or desire prolonged operations such as free tissue transfer (FTT). This study aims to outline our institution's experience with treating bloodless medicine patients and offers the first anatomically comprehensive evaluation of FTT in this population. All patients undergoing FTT from 2017 to 2020 at a single institution were retrospectively reviewed. Patients who declined blood products were selected. Outcomes of interest include flap success, operative complications, and changes to hemoglobin measurements. Ten patients undergoing 11 FTT procedures were identified. Average age was 62.4 years (SD 7.6). Most patients were female (n = 9) and Black (n = 8). Average body mass index was 31.3 (SD 5.6), American Society of Anesthesiologists Physical Status was 2.9 (SD 0.5), and Charlson Comorbidity Index was 3.8 (SD 1.1). Sites of FTT reconstruction were breast (6), lower extremity (3), and scalp (2). Average operative time was 390 min (SD 85.1), with an average estimated blood loss of 170 mL (SD 100.4). The difference between preoperative hemoglobin to first postoperative hemoglobin measurement averaged 2.2 g/dL (SD 1.4). Average patient follow-up was 12 months (SD 7.8). Flap success occurred in 10 cases. One patient with flap failure was successfully reconstructed with a second procedure. Despite a small, heterogeneous cohort, our success rate in this highly comorbid population indicates that FTT can be performed effectively for patients who cannot use blood products. Bloodless medicine protocols are beneficial to providers serving patients with transfusion restrictions and systems that strive to limit transfusion volume and risk.
引用
- Bhardwaj P, Bekeny JC, Zolper EG, et al. A single-center experience with head-to-toe microsurgical reconstruction in bloodless medicine patients. J Plast Reconstr Aesthet Surg. 2021. PMID: 34776392. doi:10.1016/j.bjps.2021.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。